Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety of Moxonidine in Indian Patients

This study has been completed.
Sponsor:
Information provided by:
Solvay Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT00160277
First received: September 9, 2005
Last updated: January 29, 2009
Last verified: January 2009

September 9, 2005
January 29, 2009
July 2005
Not Provided
Systolic blood pressure reduction
Not Provided
Complete list of historical versions of study NCT00160277 on ClinicalTrials.gov Archive Site
Piggy-back pharmacoeconomic evaluation; Safety and tolerability
Not Provided
Not Provided
Not Provided
 
Efficacy and Safety of Moxonidine in Indian Patients
Open Label, Multi-Center, Force-Titration Study to Evaluate the Efficacy and Safety of Moxonidine in Ambulatory Subjects With Essential Hypertension

The purpose of this study is to demonstrate efficacy and safety of Moxonidine in Indian subjects.

Not Provided
Interventional
Phase 3
Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Hypertension
Drug: Moxonidine
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
100
Not Provided
Not Provided

Inclusion Criteria:

Hypertension

Exclusion Criteria:

Severe concomitant diseases, CHF, secondary hypertension, severe hypertension, significant hepatic disease, unstable angina

Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
India
 
NCT00160277
S220.3.124
Not Provided
Not Provided
Solvay Pharmaceuticals
Not Provided
Study Director: Global Clinical Director Solvay Solvay Pharmaceuticals
Solvay Pharmaceuticals
January 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP